| scholarly article | Q13442814 |
| P356 | DOI | 10.4088/JCP.07M03745 |
| P698 | PubMed publication ID | 19389332 |
| P2093 | author name string | Husseini K Manji | |
| Gregory J Moore | |||
| Wayne C Drevets | |||
| Thomas W Uhde | |||
| Jorge A Quiroz | |||
| Caroline Zajac-Benitez | |||
| Bernadette M Cortese | |||
| Debra A Glitz | |||
| P433 | issue | 5 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 699-705 | |
| P577 | publication date | 2009-04-21 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients | |
| P478 | volume | 70 |
| Q27027438 | A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research |
| Q26741164 | A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts |
| Q48910946 | A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects |
| Q37394509 | A role for PKC in mediating stress-induced prefrontal cortical structural plasticity and cognitive function. |
| Q36422846 | ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder |
| Q26865366 | All the world's a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective |
| Q47802190 | Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients |
| Q33638277 | Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication |
| Q36126968 | Anterior Cortical Development During Adolescence in Bipolar Disorder |
| Q45029535 | Anterior cingulate cortical thickness is a stable predictor of recovery from post-traumatic stress disorder |
| Q38081648 | Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force |
| Q33442474 | Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide |
| Q26786245 | Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder |
| Q47386048 | Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes |
| Q36660287 | Brain gray matter phenotypes across the psychosis dimension |
| Q57792879 | Brain grey-matter volume alteration in adult patients with bipolar disorder under different conditions: a voxel-based meta-analysis |
| Q36795422 | Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus |
| Q96132661 | CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder |
| Q47745367 | Changes in white matter microstructure predict lithium response in adolescents with bipolar disorder. |
| Q36788621 | Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play |
| Q37777004 | Cognitive Impairment in Bipolar Disorder: An Overview |
| Q39066784 | Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group |
| Q33717381 | Cortical thickness differences between bipolar depression and major depressive disorder |
| Q33727970 | DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders |
| Q27027307 | Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging |
| Q36813181 | Differential effect of lithium on cell number in the hippocampus and prefrontal cortex in adult mice: a stereological study |
| Q89267161 | Discrete patterns of cortical thickness in youth with bipolar disorder differentially predict treatment response to quetiapine but not lithium |
| Q34268138 | Does lithium prevent Alzheimer's disease? |
| Q36879689 | Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder |
| Q34277299 | Effects of medication on neuroimaging findings in bipolar disorder: an updated review |
| Q27013811 | GSK-3 as potential target for therapeutic intervention in cancer |
| Q30655813 | Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder |
| Q36852817 | Gray matter atrophy rate as a marker of disease progression in AD. |
| Q48895267 | Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). |
| Q34538452 | Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study |
| Q47960042 | Increased hippocampal, thalamus and amygdala volume in long-term lithium-treated bipolar I disorder patients compared with unmedicated patients and healthy subjects |
| Q34831830 | Increased subgenual cingulate cortex volume in pediatric bipolar disorder associated with mood stabilizer exposure |
| Q48356710 | Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder |
| Q34208183 | Interpreting magnetic resonance imaging findings in bipolar disorder. |
| Q47622923 | Left medial orbitofrontal cortex volume correlates with skydive-elicited euphoric experience |
| Q90634920 | Lithium Carbonate in a Poststroke Population: Exploratory Analyses of Neuroanatomical and Cognitive Outcomes |
| Q48186224 | Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder |
| Q36480123 | Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder |
| Q36769080 | Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders |
| Q37848442 | Lithium in neuropsychiatry: a 2010 update |
| Q92949831 | Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study |
| Q34661069 | Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study |
| Q33655392 | Local gyrification index in probands with psychotic disorders and their first-degree relatives |
| Q33777999 | Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study |
| Q95315915 | Mesocortical BDNF signaling mediates antidepressive-like effects of lithium |
| Q34548121 | Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder. |
| Q37825989 | Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. |
| Q34268501 | Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach |
| Q36401907 | Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets |
| Q34660904 | Neurocircuitry of mood disorders |
| Q36321600 | Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression |
| Q39002116 | Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume |
| Q45789895 | Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response |
| Q33777958 | Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders |
| Q33929918 | Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects |
| Q34146222 | Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder |
| Q38033603 | Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. |
| Q33904292 | Posterior cerebellar vermal deficits in bipolar disorder |
| Q38675752 | Potential biomarkers for bipolar disorder: Where do we stand? |
| Q34325612 | Potential mechanisms of action of lithium in bipolar disorder. Current understanding |
| Q36443736 | Predictors of lithium response in bipolar disorder |
| Q48948464 | Progressive neurostructural changes in adolescent and adult patients with bipolar disorder |
| Q36396458 | Recent Advances in Translational Magnetic Resonance Imaging in Animal Models of Stress and Depression |
| Q45411894 | Recent advances in the understanding and management of bipolar disorder in adults. |
| Q34472152 | Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin. |
| Q38192967 | Role of lithium augmentation in the management of major depressive disorder |
| Q36247704 | Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis |
| Q34372862 | Thalamic volumes in patients with bipolar disorder |
| Q94459182 | The association between lithium use and neurocognitive performance in patients with bipolar disorder |
| Q48952912 | The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. |
| Q24651407 | The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis |
| Q24649017 | The subgenual anterior cingulate cortex in mood disorders |
| Q24626017 | Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder |
| Q46628918 | Verbal memory impairment in new onset bipolar disorder: Relationship with frontal and medial temporal morphology |
| Q36206968 | Volumetric reductions in the subgenual anterior cingulate cortex in adolescents with bipolar I disorder |
| Q98161313 | What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group |
| Q45121633 | White matter differences in euthymic bipolar I disorder: a combined magnetic resonance imaging and diffusion tensor imaging voxel-based study |
| Q92751824 | Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals |
Search more.